ArticleClinicoEconomics and outcomes research : CEOR2019

A Cost-Effectiveness Analysis Of An Adenocarcinoma Risk Prediction Multi-Biomarker Assay For Patients With Barrett's Esophagus.

Jing Hao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.